Clark Estates Inc. NY Decreases Stock Holdings in CVS Health Co. (NYSE:CVS)

Clark Estates Inc. NY trimmed its holdings in shares of CVS Health Co. (NYSE:CVS) by 9.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 37,875 shares of the pharmacy operator’s stock after selling 3,800 shares during the period. Clark Estates Inc. NY’s holdings in CVS Health were worth $2,382,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in the stock. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health in the third quarter valued at approximately $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health in the third quarter worth about $31,000. Reston Wealth Management LLC acquired a new stake in CVS Health during the 3rd quarter valued at approximately $32,000. First Community Trust NA grew its position in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after buying an additional 302 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. bought a new position in CVS Health during the 3rd quarter valued at $33,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Down 1.8 %

NYSE CVS opened at $59.02 on Wednesday. CVS Health Co. has a 12 month low of $52.71 and a 12 month high of $83.25. The company has a market capitalization of $74.27 billion, a P/E ratio of 14.98, a PEG ratio of 1.01 and a beta of 0.55. The company’s 50 day simple moving average is $59.26 and its 200 day simple moving average is $58.69. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same period last year, the company posted $2.21 EPS. Equities research analysts expect that CVS Health Co. will post 5.43 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.51%. CVS Health’s dividend payout ratio is currently 67.51%.

Analysts Set New Price Targets

CVS has been the topic of a number of recent analyst reports. Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research note on Tuesday, October 1st. TD Cowen lifted their price objective on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. UBS Group raised their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Finally, Mizuho lowered their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $70.33.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.